Prot# 3129K3-101-WW: A Phase 1/2 Study of CMC-544 Administered in Combination with Rituximab in Subjects With Follicular or Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date11/17/06 → 9/1/11

Funding

  • Wyeth (3129K3-101-WW)